Merger Mania: Celgene Still Looking; No Big Deals for Biogen, Gilead

Don’t count on Biogen (BIIB) or Gilead Sciences (GILD) engaging in a mega merger anytime soon, but Celgene (CELG) is still shopping. That’s right from the horse’s mouth. In a note published today. RBC Capital Markets analysts Michael Yee and Judy Liu weighed highlighted information they’ve gleaned from meeting with the managements at five biotech companies. Statements […]
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.